Blog
RSS FeedPosted by Michael Wonder on 20 Dec 2018
Decisions relating to the funded brands of some anti-retroviral treatments for HIV
20 December 2018 - PHARMAC is pleased to announce decisions to award sole supply for seven anti-retroviral treatments used in ...
Posted by Michael Wonder on 19 Dec 2018
Brexit: is NHS already finding it hard to get medicines?
18 December 2018 - Supply shortages and rising prices for some medicines are being reported by pharmacists and GPs. The ...
Posted by Michael Wonder on 19 Dec 2018
'Jubilant' over drug funding
19 December 2018 - Dunedin hepatitis C campaigner Hazel Heal has received an early Christmas present: news Government drug-buying agency ...
Posted by Michael Wonder on 19 Dec 2018
Women who petitioned Parliament get nothing from PHARMAC
19 December 2018 - Women who petitioned Parliament get nothing from PHARMAC’s Santa ...
Posted by Michael Wonder on 19 Dec 2018
NICE authorises MSD's Keytruda for stage III melanoma
19 December 2018 - MSD’s Keytruda has been given a green light for use within the EU as an adjuvant ...
Posted by Michael Wonder on 19 Dec 2018
As health insurance premiums rise again, consumer focus will be on value
19 December 2018 - The average 3.25 per cent rise in health insurance premiums announced today brings a respite from ...
Posted by Michael Wonder on 19 Dec 2018
NICE appraisal fees to be introduced despite opposition
14 December 2018 - Concessions made for small companies. ...
Posted by Michael Wonder on 19 Dec 2018
Agenda for the March 2019 PBAC meeting
19 December 2018 - The agenda for the March 2019 PBAC meeting is now available. ...
Posted by Michael Wonder on 19 Dec 2018
Private health insurance premiums to rise 3.25pc in April
19 December 2018 - Private health insurers are hopeful more Australians will take up cover and existing members will stop ...
Posted by Michael Wonder on 18 Dec 2018
Agenda - PBAC 2019/1 meeting
19 December 2018 - The agenda for the 2019/1 PBAC meeting is scheduled to be published later today. ...
Posted by Michael Wonder on 18 Dec 2018
Proposal to amend the distribution and access criteria for dasatinib (Sprycel)
18 December 2018 - PHARMAC is seeking feedback on a proposal to amend the distribution arrangements and access criteria for ...
Posted by Michael Wonder on 17 Dec 2018
PBS - 2018 in review (listing timelines)
18 December 2018 - The mean value for 2018 should serve as the baseline for the strategic agreement between the ...
Posted by Michael Wonder on 17 Dec 2018
Novartis weighs reinsurance tie-up to fund ultra-expensive drugs
17 December 2018 - Could reinsures solve problem of high upfront costs of developing potentially life-saving treatments? ...
Posted by Michael Wonder on 17 Dec 2018
Medicines Australia welcomes the Government’s recognition of the importance of medicines
17 December 2018 - Medicines Australia welcomes today’s Mid-Year Economic and Fiscal Outlook, announced by Treasurer the Hon. Josh Frydenberg ...
Posted by Michael Wonder on 17 Dec 2018
PHARMAC funding decision gives Kiwis with hepatitis C access to a potential cure
17 December 2018 - Life changing treatment for New Zealanders living with hepatitis C will be available from 1 February ...